K-numberK254078
Device nameHVT 2.0
ApplicantVapotherm, Inc.
Product codeBTT
Device classClass II
Decision dateApr 13, 2026
DecisionSubstantially Equivalent
Regulation868.5450
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The HVT 2.0 is a respiratory gas humidifier system that delivers warmed and humidified high-flow gases to spontaneously breathing neonates, infants, pediatric, and adult patients in hospital and sub-acute facility settings. It operates at flow rates of 2 to 45 liters per minute and is not intended for field transport or patients unable to protect their airway.

Technological characteristics

The HVT 2.0 uses a blower-driven air compressor with semi-permeable polymer tubing technology for humidification, operating at temperatures of 33–39°C with ±2°C accuracy. It accepts wall, tank, or oxygen concentrator sources; delivers FiO2 from 0.21 to 1.00 with ±2% accuracy; features extensive audible and visual alarms; and is powered by 110–240 VAC with Li-Ion battery backup. These characteristics are identical or equivalent to the secondary predicate HVT 2.0 (K203357).

Test standards cited

Testing complied with IEC 60601-1:2005 (electrical safety), IEC 60601-1-2:2014 (electromagnetic compatibility), IEC 60601-1-8:2006 (alarms), ISO 10993-1 (biocompatibility), ISO 18562 series (breathing gas pathway biocompatibility), ISO 80601-2-74 (high-flow nasal therapy devices), ISO 14971:2019 (risk management), and AIM 7351731 (RFID testing).

Substantial equivalence argument

The subject device has the same intended use as the primary predicate (Precision Flow K072845) and is technologically identical or equivalent to the secondary predicate (HVT 2.0 K203357). The expansion in indications (adding neonates) falls within the already-cleared patient populations of the primary predicate, flow rate range is a subset of cleared specifications, and minor differences in technological characteristics do not raise different safety or effectiveness questions. Comprehensive performance and biocompatibility testing demonstrates substantial equivalence.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →